Weber C, Kreuter J, Langer K
Institut für Pharmazeutische Technologie, Biozentrum Niederursel, Johann Wolfgang Goethe-Universität, Marie-Curie-Strasse 9, D-60439, Frankfurt am Main, Germany.
Int J Pharm. 2000 Mar 10;196(2):197-200. doi: 10.1016/s0378-5173(99)00420-2.
The objective of the present study was to characterise and optimise the desolvation process of human serum albumin (HSA) for the preparation of nanoparticles. Following the desolvation of the protein, the resulting nanoparticles were stabilised by the addition of varying amounts of glutaraldehyde. The particle size and the number of available amino groups on the surface of the nanoparticles were determined. The results indicated that the particle size depended mainly on the amount of desolvating agent added, but not on the amount of cross-linker. Increasing volumes of glutaraldehyde reduced the number of amino groups on the surface of HSA nanoparticles.
本研究的目的是表征并优化用于制备纳米颗粒的人血清白蛋白(HSA)去溶剂化过程。蛋白质去溶剂化后,通过添加不同量的戊二醛使所得纳米颗粒稳定。测定了纳米颗粒的粒径及其表面可用氨基的数量。结果表明,粒径主要取决于添加的去溶剂化剂的量,而不取决于交联剂的量。戊二醛体积的增加会减少HSA纳米颗粒表面的氨基数量。